Curis
CRIS
#10256
Rank
โ‚น1.08 B
Marketcap
โ‚น79.17
Share price
-4.29%
Change (1 day)
-69.12%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -โ‚น315.89

According to Curis's latest financial reports the company's current EPS (TTM) is -โ‚น340.62. In 2024 the company made an earnings per share (EPS) of -โ‚น652.48 an increase over its 2023 EPS that were of -โ‚น838.10.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น315.89-51.59%
2024-โ‚น652.48-22.15%
2023-โ‚น838.10-26.17%
2022-โ‚น1,13522.3%
2021-โ‚น928.13-25.37%
2020-โ‚น1,244-30.93%
2019-โ‚น1,801-2.02%
2018-โ‚น1,838
2016-โ‚น4,177-10%
2015-โ‚น4,641138.1%
2014-โ‚น1,94940%
2013-โ‚น1,392-25%
2012-โ‚น1,85666.67%
2011-โ‚น1,114

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น126.23-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น275.65-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น33.41-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น220.89-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น313.71-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น1,043 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น130.87-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA